UCB's Global Corporate Website

This section is intended for media and financial analysts

Search Press releases

10 Dec 2013

Acquisition of own shares

Read More
20 Nov 2013

New data from UCB’s epilepsy portfolio to be highlighted at the 67th Annual Meeting of the American Epilepsy Society

Read More
4 Nov 2013

UCB files VIMPAT® (lacosamide) in the US as monotherapy treatment in adult epilepsy patients with partial-onset seizures

Read More
25 Oct 2013

UCB receives CHMP positive opinion for Cimzia® (certolizumab pegol) in active psoriatic arthritis

Read More
25 Oct 2013

UCB Interim Report for the first nine months of 2013:

Read More
18 Oct 2013

Cimzia® (certolizumab pegol) Approved by FDA for Treatment of Adults with Active Ankylosing Spondylitis

Read More

Stay up-to-date on the latest news and information from UCB